Analysen von Matthew Weston
| 25.02.19 | Roche Neutral | Credit Suisse Group | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 31.01.19 | Novartis Neutral | Credit Suisse Group | |
| 28.01.19 | Roche Neutral | Credit Suisse Group | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 19.10.18 | Novartis Neutral | Credit Suisse Group | |
| 18.10.18 | Roche Underperform | Credit Suisse Group | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 09.08.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 27.07.18 | Roche Underperform | Credit Suisse Group | |
| 19.07.18 | Novartis Neutral | Credit Suisse Group | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.05.18 | Roche Underperform | Credit Suisse Group | |
| 20.04.18 | Novartis Underperform | Credit Suisse Group | |
| 18.04.18 | Roche Neutral | Credit Suisse Group | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group | |
| 25.01.18 | Novartis Underperform | Credit Suisse Group | |
| 31.10.16 | Novo Nordisk Neutral | Credit Suisse Group | |
| 08.08.16 | Novo Nordisk Neutral | Credit Suisse Group | |
| 20.05.15 | Merck Outperform | Credit Suisse Group | |
| 19.10.11 | Merck neutral | Credit Suisse Group | |
| 28.07.11 | Merck neutral | Credit Suisse Group | |